AstraZeneca pays $2.7 billion for diabetes stake

Thursday, December 19, 2013 - 04:30 in Mathematics & Economics

LONDON (AP) -- British drugmaker AstraZeneca PLC says it will pay $2.7 billion to buy out Bristol-Myers Squibb Co.'s stake in their partnership to develop and sell diabetes drugs....

Read the whole article on AP Health

More from AP Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net